- NF1 deficiency causes Bcl-xL upregulation in Schwann cells derived from neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors
HO-JIN PARK et al, 2013, International Journal of Oncology CrossRef - Inhibition of Bcl-2 family members sensitises soft tissue leiomyosarcomas to chemotherapy
Marieke A de Graaff et al, 2016, British Journal of Cancer CrossRef - BNIP3 Regulates AT101 [(-)-Gossypol] Induced Death in Malignant Peripheral Nerve Sheath Tumor Cells
Niroop Kaza et al, 2014, PLoS ONE CrossRef - Programmed cell death, redox imbalance, and cancer therapeutics
Xiaofeng Dai et al, 2021, Apoptosis CrossRef - The alkaloid emetine sensitizes ovarian carcinoma cells to cisplatin through downregulation of bcl-xL
QI SUN et al, 2015, International Journal of Oncology CrossRef - Molecular-guided therapy predictions reveal drug resistance phenotypes and treatment alternatives in malignant peripheral nerve sheath tumors
Jacqueline D Peacock et al, 2013, Journal of Translational Medicine CrossRef - Neurofibromin Deficiency Causes Epidermal Growth Factor Receptor Upregulation through the Activation of Ras/ERK/SP1 Signaling Pathway in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheet Tumor
Gun-Hoo Park et al, 2021, International Journal of Molecular Sciences CrossRef - Interferon-Induced Transmembrane Protein 1 (IFITM1) Is Downregulated in Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors
Gun-Hoo Park et al, 2024, International Journal of Molecular Sciences CrossRef - Screening for Potential Targets for Therapy in Mesenchymal, Clear Cell, and Dedifferentiated Chondrosarcoma Reveals Bcl-2 Family Members and TGFβ as Potential Targets
Jolieke G. van Oosterwijk et al, 2013, The American Journal of Pathology CrossRef - Survivin and YM155: How faithful is the liaison?
Anke Rauch et al, 2014, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef - TAGLN expression is upregulated in NF1-associated malignant peripheral nerve sheath tumors by hypomethylation in its promoter and subpromoter regions
GUN-HOO PARK et al, 2014, Oncology Reports CrossRef